than 360 ipsilateral (to the lesioned side) turns over a one-hour period were selected for microdialysis studies (see below).
Viral injections.
For detection of glutamate in the GPe and in the dStr from ex vivo slices, 135 nl and 360 nl of GFAP-iGluSnFr adeno-associated virus (AAV) was injected into wild type mice at (in mm) 0.35 caudal, 1.95 lateral, 4.00 ventral from bregma and 0.7 rostral, 2.3 lateral, 3.4 and 3.0 ventral from bregma, respectively.
For astrocyte-specific optogenetic activation, either a viral or a transgenic strategy was used. Gfap
Cre mouse line was crossed with R26 LSL-hChR2(H134R)-eYFP mouse line to obtain astrocyte-specific expression of channelrhodopsin (ChR2) The locations of the targeted injections were visually inspected under epifluorescence microscopy in ex vivo slices and histologically verified post hoc. AAVs with serotype 9 were used for this study. AAVs were obtained from Penn Vector Core or custom packaged by Virovek. All AAVs were injected into mice (postnatal day 28-35) at a final titer of 10 12 -10 13 genome copies/ml, using the same standard procedures as 6-OHDA injections (see above). Recordings were performed 28-40 days postoperatively.
Visualized recording in ex vivo brain slices. Mice aged postnatal day 55-75 were anesthetized with a ketamine-xylazine mixture and perfused transcardially with ice-cold artificial cerebrospinal fluid (aCSF) containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 2.0
CaCl 2 , 1.0 MgCl 2 , 25 NaHCO 3 , and 12.5 glucose, bubbled continuously with carbogen (95% O2 and 5% CO2). The brains were rapidly removed, glued to the stage of a vibrating microtome (Leica Instrument), and immersed in ice-cold aCSF. Parasagittal ex vivo slices containing the dStr and the GPe were cut at a thickness of 240 µm and transferred to a holding chamber, where they were submerged in aCSF at 35 ºC for 30 minutes, and returned to room temperature before recording. For GPe astrocytes recordings and imaging (see below), ex vivo slices were submerged in aCSF at 35 ºC for 30 minutes in the dark with 300 nM sulforhodamine 101 (SR101, Life Technologies), then transferred to dye-free aCSF at room temperature for at least 30 min before experimentation.
Ex vivo slices were then transferred to a small volume (~0.5 ml) Delrin recording chamber that was mounted on a fixed-stage, upright microscope (Olympus). Neurons and astrocytes were visualized using differential interference contrast optics (Olympus), illuminated at 735 nm (Thorlabs), imaged with a 60× 1.0 NA water-immersion objective (Olympus) and a CCD camera (Photometrics). GPe neurons were identified by their somatic morphology. GPe astrocytes were identified by their relative round and small cell bodies along with fluorescence signal from SR101 (Nimmerjahn et al., 2004) examined under epifluorescence microscopy with a daylight (6,500 K) LED (Thorlabs) and an appropriate filter cube (Semrock).
Recordings were made at room temperature (20-22 ºC) with patch electrodes fabricated from capillary glass (Sutter CsMeSO 3 , 10 Na 2 phosphocreatine, 5 HEPES, 5 tetraethylammonium-Cl, 2 Mg 2 ATP, 1 QX314-Cl, 0.5 Na 3 GTP, 0.25 EGTA, and 0.2% (wt/vol) biocytin, pH adjusted to 7.25-7.30 with CsOH. For astrocyte recordings, the internal solution consisted of (in mM): 135
KMeSO 4 , 5 KCl, 10 Na 2 phosphocreatine, 5 HEPES, 5 EGTA, 2 Mg 2 ATP, 0.5 Na 3 GTP, 0.5 CaCl 2 , pH adjusted to 7.25-7.30 with KOH. The liquid junction potential for this internal solution was ~7 mV and was not corrected for. Both internal solutions had an osmolarity of ~300 mOsm. Somatic whole-cell patch-clamp recordings were obtained with an amplifier (Molecular Devices). The signal for voltage clamp recordings was filtered at 1 kHz and digitized at 10 kHz with a digitizer (Molecular Devices). For currentclamp recordings, the amplifier bridge circuit was adjusted to compensate for electrode resistance and subsequently monitored.
Stimulus generation and data acquisition were performed using pClamp10 (Molecular Devices).
To study the dStr inputs to the GPe, striatopallidal axons were stimulated within the dStr using electrical stimulus delivered with a constant-current isolator (Digitimer) and a concentric bipolar electrode (Frederick Haer & Co) in the presence of CGP55845 (1 µM), R-CPP (10 µM), and NBQX (5 µM). Except for the analysis of stimulus-response function, electrical stimulation was adjusted to produce initial IPSCs of 100-500 pA. To measure tonic NMDA currents, GPe neurons were stepped from -120 mV to +70 mV for 2 s or ramped from -120 mV to +50 mV in 500 ms in the presence of TTX (1 µM). R-CPP (10 µM) was subsequently bath applied.
NMDA (R-CPP-sensitive) currents were calculated offline. Alternatively, GPe neurons were voltage-clamped at +40 mV, in the presence of TTX (1 µM). The net inward current induced with R-CPP (10 µM) application was measured. Astrocyte current-voltage relationship was determined using a 500 ms-voltage ramp from -150 mV to +50 mV. For optogenetics and uncaging experiments, blue (peak at 450 nm) excitation wavelength from two daylight-LEDs (Thorlabs) was delivered to the tissue slice bidirectionally from both the objective and the condenser with the aid of 520 nm dichroic beamsplitters (Semrock). The field of illumination that centered around the recorded cells was ~500 µm in diameter. The duration of all light pulses was 10 ms for RuBi-glutamate (20 µM) and Rubi-GABA (20 µM) uncaging experiments. TTX (1 µM) and BaCl 2 (200 µM) were included in all uncaging experiments. NBQX (5 µM)
and R-CPP (20 µM) were included for glutamate-uncaging, while CGP55845 (1 µM) and picrotoxin (100 µM) were included for GABA-uncaging. To activate ChR2, 1-2 s period of sustained light or pulsed light (50 ms each at 10 Hz) were used. Astrocytic and STN-inputs were conditioned immediately before electrical stimulation of the striatopallidal input.
Data analyses were done with ClampFit10 (Molecular Devices), MiniAnalysis6 (Synaptosoft), IgorPro6 (Wavemetrics), and MATLAB8 (MathWorks). We elected to use the coefficient of variation (CV) instead of the paired-pulse ratio (PPR) to determine the locus of synaptic modulation for three reasons. First, CV generally covaries with PPR in our experiments (not shown). This relationship is consistent with what is commonly observed in literature (Choi and Lovinger, 1997; Dolen et al., 2013) . Second, CV is a more sensitive measure of changes in release than PPR. This reasoning is based on a stronger correlation (Spearman r value = -0.9015) between changes in CV and changes in IPSC amplitude when compared with the correlation between changes in PPR and changes in IPSC amplitude (Spearman r value = -0.6295). Third, as the percentage change in the PPR is more compressed compared to the percentage change in CV, negative results with PPR measurement cannot be easily interpreted. For strontium-based quantal analysis, the maximal peak amplitude within 100 ms and quantal events within 300 ms after striatal stimulation were quantified.
GCaMP3 and iGluSnFR imaging. Ex vivo brain slices were prepared as described above. The imaged planes were 20-35 µm below the slice surface. 3-5 astrocytes on the same focal plane were typically imaged in each field. GCaMP3 signals, iGluSnFR, and SR101 signals of astrocytes were acquired with a 60× 1.0 NA water-immersion objective, spinning-disk unit (Yokogawa), and an electron multiplying CCD (Photometrics). Image acquisition was achieved in SlideBook6 (Intelligent Imaging Innovations). GCaMP3 and iGluSnFR were excited with a 50 mW 488 nm laser (Coherent) operating at 1% power, with an exposure time of 500 ms and 200 ms, respectively. SR101 labeling was excited with a 50 mW 561 nm laser (Coherent) operating at 1% power and with an exposure time of 150 ms. The emitted fluorescence signals were imaged after passing through a dual-band (488 and 561 nm) emission filter (Semrock).
Analysis of changes in fluorescence intensity (∆F/F) was performed using Fiji (Schindelin et al., 2012) and Python3
(https://github.com/chanlab/Python-Scripts/blob/master/astrocyteCalciumPeakDetection.py; https://github.com/chanlab/PythonScripts/blob/master/csvSummaryFileGenerator.py).
For GCaMP3 images, somatic regions of interests (ROIs) were generated semi-automatically (https://github.com/chanlab/Fiji-Scripts/blob/master/GCaMP_flatFieldAndPickROIs_auto.ijm) based on the SR101 signal. Changes in somatic fluorescence intensity during the ten-minute recording period was calculated (https://github.com/chanlab/FijiScripts/blob/master/GCaMP_deltaF_auto.ijm). A signal was declared as a Ca 2+ transient if it exceeded the baseline by greater than two standard deviations. GCaMP3 signals in the astrocytic processes were not quantified because of the poor resolving power associated with the heavy myelination in the GPe. As a prolonged imaging session (> 10 min) consistently results in phototoxicity, properties of the calcium transients were not compared within the same field. Instead, at least one drug-free image field from each animal was used as an internal control. Additionally, within-slice and sister-slice comparisons were performed whenever possible.
For iGluSnFR images, ROIs were generated manually and included two iGluSnFR-positive soma, two iGluSnFR-positive processes, and one background (i.e. with no visible iGluSnFR-positive elements). Images were aligned in the x-and y-axis (https://github.com/chanlab/Fiji-Scripts/blob/master/iGluSnFR_aLineImages.ijm). Median fluorescence intensities were calculated in each ROI before and after the addition of glutamate or NBQX over a five-minute period (https://github.com/chanlab/FijiScripts/blob/master/iGluSnFR_zProfileUnderROI.ijm). A linear subtraction was performed in a subset of the experiments with iGluSnFR to correct issues with photostability (Marvin et al., 2013) .
Astrocyte morphometric analysis. Ex vivo brain slices were prepared as described above. GPe astrocytes were patch clamped using standard procedures (see above). Alexa Fluor 594 hydrazide (100 µM) was included in the KMeSO4-based internal solution described above and astrocytes were voltage-clamped at −80 mV for at least thirty minutes. Astrocytes were then imaged with either a 60× 1 Automated colocalization analysis was performed in Fiji (https://github.com/chanlab/FijiScripts/blob/master/colocalizationAnalysisOffset.ijm). Briefly, Pearson's correlation coefficients (r) were calculated through each zplane within a 20 × 20 µm-ROI for each channel. ROIs for one channel were offset in all four cardinal directions in twenty separate 1 µm-steps. For each field analyzed, the degree of random correlation was calculated using twenty different pairs of non-overlapping ROIs and subtracted from the Pearson correlation for that field.
A semi-automated cell density analysis was performed in Fiji (https://github.com/chanlab/FijiScripts/blob/master/cellBodyPicker.ijm). Briefly, ten z-stacks were acquired in the dStr and GPe of a parasagittal section from three different lateromedial levels (approximately 2.5 mm, 2.1 mm, and 1.7 mm from Bregma) (Hernandez et al., 2015) and were assigned as lateral, intermediate, and medial, respectively. Each z-stack is 212 µm × 212 µm × 10 µm. Thirty total z-stacks per brain region was taken. For coronal sections from 6-OHDA lesioned mice and naïve controls, total 20-22 z-stacks from three different rostrocaudal
GPe (approximately 0.10 mm, 0.46 mm, and 0.82 mm posterior to Bregma) were taken. Cells were identified in maximum zprojections based on DAPI fluorescence, and individual ROIs were created for each cell. For each ROI, cell identity was determined based on the fluorescence intensity of neuronal (NeuN), astrocytic (Gfap Cre ;R26 LSL-tdTomato ), and oligodendrocytic (Olig2) markers.
Cell counts were normalized by volume to estimate the cell density for each z-stack.
Fluorescence-activated cell sorting and quantitative PCR. Experimental procedures and data processing for fluorescence-activated cell sorting (FACS) and quantitative PCR (qPCR) were similar to analysis in our previous studies (Plotkin et al., 2014; Sheets et al., 2011) . Ex vivo slices were prepared as described above, striata were microdissected, and single-cell suspensions were generated using a combination of enzymatic and mechanical dissociation procedures. Direct-pathway SPNs and indirect-pathway SPNs were purified using FACS on a cell sorter (BD Biosciences), based on tdTomato or eGFP expression. Dead cells were excluded based on the 4′,6-diamidino-2-phenylindole (DAPI, Life Technologies) or propidium iodide (Life Technologies) labeling. Approximately 10,000 cells from each mouse were collected, lysed using RealTime ready Cell Lysis Buffer (Roche), stored at -80 ºC, and used for qPCR analysis.
Immediately following total RNA isolation using RNAeasy Micro Kit (Qiagen), first strand cDNA synthesis was performed using cDNA Supermix (Quanta Biosciences). cDNAs were then frozen at -20 ºC until used. Desalted primers were custom synthesized (Invitrogen) and intron-spanning whenever possible. qPCRs were run in triplicate using Fast SYBR Green Mastermix (Applied Biosystems) on a qPCR instrument (Roche Applied Science). Negative controls for contamination from extraneous and genomic DNA were run for every gene target. The cycling protocol consisted of 95 ºC for 5 min followed by 45 cycles at 95 ºC for 10 s, 60 ºC for 10 s, and 72 ºC for 10s. The PCR cycle threshold (C T ) values were determined by the maxima of the second derivative of the fluorescence response curves. Melting curves were performed to verify amplification of single PCR products. A weighted C T was calculated from seven reference genes (Atp5b, Cyc1, Eif4a2, Gapdh, H2afz, Sdha, and Uchl1) for each cell sample based on their expression stability for normalization (Chan et al., 2012; Fan et al., 2012; Glajch et al., 2016; Plotkin et al., 2014; Plotkin et al., 2013) . The mRNA levels in each group of samples were characterized by their median values. Quantification of transcript expression changes was performed using the ΔΔC T method. Results were presented as fold changes relative to the median of their respective naïve controls.
Quantitative microdialysis and LC-MS measurements. Microdialysis probes (2 mm) were implanted into the GPe (at AP -1.5 mm, ML +3.2 mm, DV -6.5 mm) of male rats between 175 and 225 g. Probes were secured to the skull by acrylic dental cement and metallic screws. Microdialysis experiments were run 24 hr after probe implantation. Microdialysis probes were flushed at a flow rate of 2 µl/min with a solution with the following composition (in mM): 148 NaCl, 2.7 KCl, 1.2 CaCl 2 , and 0.85 MgCl 2 for 2 hr using a syringe pump (Chemyx). Perfusion flow rate was then reduced to 1 µl/min and stable-isotope containing-solution (see below) was infused at 1 µl/min for 1 hr prior to sample collection. Probe placement for each animal was histologically verified. Quantitative microdialysis procedures were employed as described with slight modifications (Hershey and Kennedy, 2013) . In brief, 100 nM 13 Cglutamate (1 hr) and 13 C-glutamine (1 hr) were sequentially added to the microdialysis fluid. The amount of SIL analyte which exits the microdialysis probe was then quantified using a benzoylation LC-MS/MS method. Glutamate and glutamine concentrations in the interstitial space were calculated from levels of SIL analytes that exit the probe relative to the native neurochemical ( 12 C-glutamate and 12 C-glutamine) entering the probe. Samples (10 µl) were collected at 10 min intervals. To 10 µl samples, 5 µl of 100 mM sodium tetraborate was added to the collected 10 µl dialysate sample. Then, 5 µl of 2% (vol/vol) benzoyl chloride in acetonitrile was added to the mixture to initiate the benzoylation reaction. 5 µl of a stable 13 C-benzoylated isotope internal standard mixture was then added to improve quantitation. A UHPLC system (Thermo Fisher Scientific) automatically injected 5 µl of the sample onto an HPLC column (Waters Corporation). Mobile phase A consisted of 10 mM ammonium formate and 0.15% (vol/vol) formic acid. Mobile phase B was pure acetonitrile. Analytes were detected by a mass spectrometer (Thermo Fisher Scientific) operating in positive mode using dynamic multiple reaction monitoring. Run times were 5.5 min per sample. Each trial included four naïve and four 6-OHDA-lesioned rats. Two separate trials were conducted. and pound signs denote statistical significance level (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001).
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Three Gfap Cre ;R26 LSL-tdTomato mice were used for these quantifications. branch length (left, naïve = 1.7 ± 0.2 mm, n = 11; 6-OHDA =1.7 ± 0.2 mm, n = 12; P = 0.9134, Mann-Whitney U test), enclosing radius (middle, naïve = 38.0 ± 3.0 µm, n = 11; 6-OHDA = 41.0 ± 6.0 µm, n = 12; P = 0.8439, Mann-Whitney U test) and primary branch number (right, naïve = 14.0 ± 1.0, n = 11; 6-OHDA = 14.0 ± 1.5, n = 12; P = 0.3309, Mann-Whitney U test). Asterisks denote statistical significance level (**P < 0.01, ****P < 0.0001, Mann-Whitney U test). Box plots summarizing relative interstitial levels of dopamine (dop; naïve = 1.00 ± 0.14-fold, n = 8 rats; 6-OHDA = 0.15 ± 0.11-fold, n = 8 rats; P = 0.0002, Mann-Whitney U test), glutamate (glu; naïve = 1.00 ± 0.15-fold, n = 8 rats; 6-OHDA = 0.61 ± 0.17, n = 8 rats; P = 0.0070, Mann-Whitney U test), and glutamine (gln; naïve = 1.00 ± 0.12-fold, n = 8 rats; 6-OHDA = 0.79 ± 0.10-fold, n = 8 rats; P = 0.0827, Mann-Whitney U test) in the GPe in vivo from naïve rats and chronic 6-OHDA lesioned rats. Asterisks denote statistical significance level (**P < 0.01, ***P < 0.001, Mann-Whitney U test). identified based on genetic labelling using Gfap Cre ;R26 LSL-tdTomato mice. A total of two mice were used for this quantification.
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